Latest News in the pharma Industry

Research & Development

Allergan and Gedeon Richter to present data from Cariprazine trials at ECNP annual meeting

Allergan and Gedeon Richter to present data from Cariprazine trials at ECNP annual meeting

26 Aug 2015

Read more 
Oncodrone receives €2.5 million Eurostars grant

Oncodrone receives €2.5 million Eurostars grant

26 Aug 2015

Read more 
BMS and Pfizer to present new data on Eliquis (apixaban) at the ESC Congress 2015

BMS and Pfizer to present new data on Eliquis (apixaban) at the ESC Congress 2015

25 Aug 2015

Read more 
NIH study shows no benefit of omega-3 or other nutritional supplements for cognitive decline

NIH study shows no benefit of omega-3 or other nutritional supplements for cognitive decline

25 Aug 2015

Read more 
Takeda announces EMA acceptance of ixazomib's MAA for patients with relapsed/refractory multiple myeloma

Takeda announces EMA acceptance of ixazomib's MAA for patients with relapsed/refractory multiple myeloma

24 Aug 2015

Read more 
Alkermes provides update on FDA review of Aristada for the treatment of schizophrenia

Alkermes provides update on FDA review of Aristada for the treatment of schizophrenia

24 Aug 2015

Read more 
Jardiance demonstrated cardiovascular risk reduction in people with type 2 diabetes at high risk for CV events

Jardiance demonstrated cardiovascular risk reduction in people with type 2 diabetes at high risk for CV events

21 Aug 2015

Read more 
Presage Biosciences Receives Strategic Investment from Takeda

Presage Biosciences Receives Strategic Investment from Takeda

20 Aug 2015

Read more 
Bavarian Nordic Initiates Phase I Clinical Trial of MVA-BN in Respiratory Syncitial Virus

Bavarian Nordic Initiates Phase I Clinical Trial of MVA-BN in Respiratory Syncitial Virus

19 Aug 2015

Read more 
New Data Show Stiolto Respimat Provides Clinically Meaningful Improvements in COPD Health-Related Quality of Life Measure

New Data Show Stiolto Respimat Provides Clinically Meaningful Improvements in COPD Health-Related Quality of Life Measure

18 Aug 2015

Read more 
FDA Accepts sBLA for Keytruda, Merck’s Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review

FDA Accepts sBLA for Keytruda, Merck’s Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review

18 Aug 2015

Read more 
Results from B-YOND Extension Study Reinforce Long-Term Clinical Profile of Alprolix for the Treatment of Hemophilia B

Results from B-YOND Extension Study Reinforce Long-Term Clinical Profile of Alprolix for the Treatment of Hemophilia B

17 Aug 2015

Read more